These results indicate that sparse detection of NAbs in neonates is due to combined action of symptomatic infection particularly hindering the placental transfer of anti-RBD IgG and of a skewing of maternal NAb production toward IgA and IgM isotypes, which do not cross the placenta, in response to SARS-CoV-2 infection. The gene discussed is CD79A; the disease is infection.